Claus R - Search Results

1

Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.

Stosch JM, Heumüller A, Niemöller C, Bleul S, Rothenberg-Thurley M, Riba J, Renz N, Szarc Vel Szic K, Pfeifer D, Follo M, Pahl HL, Zimmermann S, Duyster J, Wehrle J, Lübbert M, Metzeler KH, Claus R, Becker H. Stosch JM, et al. Among authors: claus r. Br J Haematol. 2018 Sep;182(6):830-842. doi: 10.1111/bjh.15461. Epub 2018 Jul 5. Br J Haematol. 2018. PMID: 29974943 Free article.

2

Epigenetic targets in hematopoietic malignancies.

Claus R, Lübbert M. Claus R, et al. Oncogene. 2003 Sep 29;22(42):6489-96. doi: 10.1038/sj.onc.1206814. Oncogene. 2003. PMID: 14528273 Review.

3

Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents.

Claus R, Almstedt M, Lübbert M. Claus R, et al. Semin Oncol. 2005 Oct;32(5):511-20. doi: 10.1053/j.seminoncol.2005.07.024. Semin Oncol. 2005. PMID: 16210092 Review.

4

Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.

Claus R, Fliegauf M, Stock M, Duque JA, Kolanczyk M, Lübbert M. Claus R, et al. J Leukoc Biol. 2006 Dec;80(6):1462-72. doi: 10.1189/jlb.0106005. Epub 2006 Sep 25. J Leukoc Biol. 2006. PMID: 17000900

5

Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.

Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko-Dorfs N, Maharry K, Whitman SP, Schmittgen TD, Lübbert M, Marcucci G, Bloomfield CD, Plass C. Hackanson B, et al. Among authors: claus r. Cancer Res. 2008 May 1;68(9):3142-51. doi: 10.1158/0008-5472.CAN-08-0483. Cancer Res. 2008. PMID: 18451139

6

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.

Flotho C, Claus R, Batz C, Schneider M, Sandrock I, Ihde S, Plass C, Niemeyer CM, Lübbert M. Flotho C, et al. Among authors: claus r. Leukemia. 2009 Jun;23(6):1019-28. doi: 10.1038/leu.2008.397. Epub 2009 Feb 5. Leukemia. 2009. PMID: 19194470

7

Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients.

Lübbert M, Bertz H, Rüter B, Marks R, Claus R, Wäsch R, Finke J. Lübbert M, et al. Among authors: claus r. Bone Marrow Transplant. 2009 Nov;44(9):585-8. doi: 10.1038/bmt.2009.64. Epub 2009 Apr 13. Bone Marrow Transplant. 2009. PMID: 19363531 Clinical Trial.

8

Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting.

Lübbert M, Bertz H, Wäsch R, Marks R, Rüter B, Claus R, Finke J. Lübbert M, et al. Among authors: claus r. Bone Marrow Transplant. 2010 Apr;45(4):627-32. doi: 10.1038/bmt.2009.222. Epub 2009 Aug 31. Bone Marrow Transplant. 2010. PMID: 19718057

9

DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.

Claus R, Plass C, Armstrong SA, Bullinger L. Claus R, et al. Future Oncol. 2010 Sep;6(9):1415-31. doi: 10.2217/fon.10.110. Future Oncol. 2010. PMID: 20919827 Review.

10

Quantitative analyses of DAPK1 methylation in AML and MDS.

Claus R, Hackanson B, Poetsch AR, Zucknick M, Sonnet M, Blagitko-Dorfs N, Hiller J, Wilop S, Brümmendorf TH, Galm O, Platzbecker U, Byrd JC, Döhner K, Döhner H, Lübbert M, Plass C. Claus R, et al. Int J Cancer. 2012 Jul 15;131(2):E138-42. doi: 10.1002/ijc.26429. Epub 2011 Nov 28. Int J Cancer. 2012. PMID: 21918973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters